Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRONWOMAN trial for iron deficiency anaemia in pregnancy
ACTRN12619000283178Phase 3Not yet recruiting
- Sponsor
- Dr Amanda Henry
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ferric carboxymaltose, Iron and sodium chloride in iron deficiency anemia (IDA), sponsored by Dr Amanda Henry. Primary endpoint: Correct identification of treatment allocation. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
ferric carboxymaltoseIronsodium chloride
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12619000283178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000283178.